跳至主要内容
临床试验/JPRN-UMIN000031866
JPRN-UMIN000031866已完成未知

An exploratory study to identify biomarkers of resistance to chemotherapy in multiple myeloma - biomarker study in MM

The Institute of Medical Science, The University of Tokyo0 个研究点目标入组 14 人开始时间: 2018年3月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
14

研究概览

简要总结

Results: We identified several driver mutations by combined analysis of next-generation sequencing and existing databases of candidate oncogenes. Furthermore, relapse was detected more sensitively by monitoring the circulating cfDNA with these driver mutations than by conventional serum free-light chain examination. Conclusion: These results suggest the potential utility of cfDNA in the PB plasma of patients as a relevant early biomarker for MM relapse.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who are found to be inappropriate for this trial as judged by the principal investigator or the sub-investigator

研究者

发起方
The Institute of Medical Science, The University of Tokyo

相似试验